Steward Partners Investment Advisory, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 43,755 shares of CPRX stock, worth $927,168. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,755
Previous 1,273
3337.16%
Holding current value
$927,168
Previous $26,000
3980.77%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CPRX
# of Institutions
390Shares Held
99.9MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$396 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$180 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$117 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$72.5 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$66.4 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.18B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...